Technology Platforms
Technology Platforms
Driving Innovation Through Novel Advanced Technologies
Our proprietary and scalable platform technologies are designed to solve formulation challenges, enhance stability, and enable patient-friendly administration routes.
Novel Formulation
-
ADC
- IV to SC
- Lyo to Liquid
-
Fusion Proteins
- Low Endotoxin Lyo to Liquid
-
Biosimilars
- HCLV
- Lyo to Liquid
-
Bispecific
- IV to SC
- Lyo to Liquid
- Bi to Tri Specific
-
Glycoprotein
- HCLV
- Lyo to Liquid
-
r-Hormones
- HCLV
- Lyo to Liquid
-
Peptibodies
- Lyo to Liquid
-
Peptides
- Lyo to Liquid
-
Cell and gene Therapy
- Establish route of Administration
Looking for specific disease area support?
See Therapeutic Areas We Support
Apply Our Platforms